New Nordic Healthbrands AB (publ)
Symboli: NNH.ST
STO
19.6
SEKMarkkinahinta tänään
-12.6719
P/E-suhde
0.0178
PEG-suhde
121.43M
MRK Cap
- 0.00%
DIV Tuotto
New Nordic Healthbrands AB (publ) (NNH-ST) Tilinpäätöstiedotteet
Tase
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 53.85 | 13.8 | 10.7 | 11.9 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.net-receivables | 433.07 | 101.9 | 116.5 | 97 | ||||||||||||||||
balance-sheet.row.inventory | 408.14 | 105.1 | 110.2 | 116.5 | ||||||||||||||||
balance-sheet.row.other-current-assets | 54.39 | 9.1 | 0 | 2.8 | ||||||||||||||||
balance-sheet.row.total-current-assets | 949.46 | 230 | 237.3 | 228.2 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 16.37 | 4.4 | 3.2 | 2.2 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.intangible-assets | 11.6 | 0.5 | 3.6 | 3 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 11.6 | 0.5 | 3.6 | 3 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0.92 | 0.9 | 7.5 | 0.6 | ||||||||||||||||
balance-sheet.row.tax-assets | 10.23 | 10.2 | 7 | 4.2 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 33.43 | 3.1 | -7 | 0 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 72.55 | 19.1 | 14.3 | 10.1 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 1022 | 249.1 | 251.7 | 238.4 | ||||||||||||||||
balance-sheet.row.account-payables | 324.31 | 86.4 | 66.5 | 66 | ||||||||||||||||
balance-sheet.row.short-term-debt | 135.72 | 26.6 | 48.3 | 24.4 | ||||||||||||||||
balance-sheet.row.tax-payables | 10.27 | 2 | 1.7 | 3.6 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 8.22 | 2.2 | 1.6 | 0 | ||||||||||||||||
Deferred Revenue Non Current | -0.27 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0.94 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 66.61 | 25.3 | 22.6 | 7.6 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 9.16 | 2.8 | 1.6 | 3.4 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-liab | 583.3 | 143 | 139.1 | 118 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 24.78 | 6.2 | 6.2 | 6.2 | ||||||||||||||||
balance-sheet.row.retained-earnings | 300.07 | 96.8 | 106.4 | 114.1 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 413.92 | 99.8 | 106.4 | 0.5 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | -300.07 | -96.8 | -106.4 | -0.5 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 438.7 | 106 | 112.6 | 120.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 1022 | 249.1 | 251.7 | 238.4 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-equity | 438.7 | 106 | 112.6 | 120.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 1022 | - | - | - | ||||||||||||||||
Total Investments | 9.57 | 0.9 | 7.5 | 0.6 | ||||||||||||||||
balance-sheet.row.total-debt | 143.94 | 28.8 | 48.3 | 24.4 | ||||||||||||||||
balance-sheet.row.net-debt | 90.09 | 15 | 37.6 | 12.5 |
Kassavirtalaskelma
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -8.61 | -6.2 | -4.7 | 28.5 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 2.03 | 1.2 | 1.6 | 0.9 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 14.87 | 31.7 | -3.4 | -31.1 | ||||||||||||||||
cash-flows.row.account-receivables | -3.85 | 2.8 | -10.4 | -4.6 | ||||||||||||||||
cash-flows.row.inventory | -12.04 | 4.9 | 6.3 | -35.8 | ||||||||||||||||
cash-flows.row.account-payables | 30.77 | 24 | 0.8 | 9.3 | ||||||||||||||||
cash-flows.row.other-working-capital | 0.66 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-non-cash-items | -1.29 | 1.3 | -9 | -6.2 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 5.48 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -3.16 | -3.1 | -3 | -2.7 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0.3 | 0 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0.11 | -0.3 | 0 | -0.3 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -3.05 | -3.4 | -2.6 | -3 | ||||||||||||||||
cash-flows.row.debt-repayment | -28.42 | -21.2 | -24.3 | -22.9 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -7.7 | -9.3 | ||||||||||||||||
cash-flows.row.other-financing-activites | -7.01 | 0 | 48.7 | 44.2 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -3.96 | -21.2 | 16.6 | 12.1 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.14 | -0.3 | 0.3 | 0.3 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -1.68 | 3.1 | -1.2 | 1.5 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 53.85 | 13.8 | 10.7 | 11.9 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 55.53 | 10.7 | 11.9 | 10.4 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 5.48 | 28 | -15.5 | -7.9 | ||||||||||||||||
cash-flows.row.capital-expenditure | -3.16 | -3.1 | -3 | -2.7 | ||||||||||||||||
cash-flows.row.free-cash-flow | 2.31 | 25 | -18.4 | -10.6 |
Tuloslaskelmarivi
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 537.81 | 533.8 | 487.5 | 514.8 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 370.92 | 536.3 | 169 | 164.8 | ||||||||||||||||
income-statement-row.row.gross-profit | 166.89 | -2.5 | 318.5 | 350 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 0.67 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 139.45 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 323.2 | 56.7 | ||||||||||||||||
income-statement-row.row.operating-expenses | 360.46 | 0.7 | 323.2 | 321.5 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 546.99 | 537 | 492.3 | 486.3 | ||||||||||||||||
income-statement-row.row.interest-income | 0.72 | 0.1 | 0 | 0 | ||||||||||||||||
income-statement-row.row.interest-expense | 2.61 | 2.8 | 1.5 | 0.6 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -2.07 | -2.8 | -0.4 | -0.6 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 323.2 | 56.7 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | -2.07 | -2.8 | -0.4 | -0.6 | ||||||||||||||||
income-statement-row.row.interest-expense | 2.61 | 2.8 | 1.5 | 0.6 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 2.03 | 1.2 | 2.8 | 0.9 | ||||||||||||||||
income-statement-row.row.ebitda-caps | -7.15 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | -9.19 | -3.2 | -4.7 | 28.5 | ||||||||||||||||
income-statement-row.row.income-before-tax | -11.26 | -5.9 | -5.2 | 28 | ||||||||||||||||
income-statement-row.row.income-tax-expense | -1.09 | 0.3 | -2.3 | 6.7 | ||||||||||||||||
income-statement-row.row.net-income | -10.17 | -6.2 | -2.8 | 21.3 |
Usein kysytty kysymys
Mikä on New Nordic Healthbrands AB (publ) (NNH.ST) taseen loppusumma?
New Nordic Healthbrands AB (publ) (NNH.ST) kokonaisvarat ovat 249060000.000.
Mikä on yrityksen vuotuinen liikevaihto?
Vuotuinen liikevaihto on 272769000.000.
Mikä on yrityksen voittomarginaali?
Yrityksen voittomarginaali on 0.310.
Mikä on yrityksen vapaa kassavirta?
Vapaa kassavirta on 0.373.
Mikä on yrityksen nettovoittomarginaali?
Nettovoittomarginaali on -0.019.
Mikä on yrityksen kokonaistulot?
Kokonaisliikevaihto on -0.017.
Mikä on New Nordic Healthbrands AB (publ) (NNH.ST) nettovoitto (nettotulos)?
Nettovoitto (nettotulos) on -6194000.000.
Mikä on yrityksen kokonaisvelka?
Kokonaisvelka on 28824000.000.
Mikä on yrityksen toimintakulujen määrä?
Toimintakulut ovat 672000.000.
Mikä on yrityksen kassan määrä?
Yrityksen kassavarat ovat 9865000.000.